Ausgabe 7/2016
Inhalt (12 Artikel)
Original Article
Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas
Pamela L. Beatty, Rick van der Geest, Jana G. Hashash, Takashi Kimura, Dmitriy Gutkin, Randall E. Brand, Olivera J. Finn
Focussed Research Review
Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
Anja Derer, Benjamin Frey, Rainer Fietkau, Udo S. Gaipl
Focussed Research Review
Improving cancer immunotherapy with DNA methyltransferase inhibitors
Mohammad H. Saleh, Lei Wang, Michael S. Goldberg
Focussed Research Review
PD-L1-specific T cells
Shamaila Munir Ahmad, Troels Holz Borch, Morten Hansen, Mads Hald Andersen
Focussed Research Review
Lessons learned from cancer vaccine trials and target antigen choice
Lisa H. Butterfield
Focussed Research Review
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
Suresh Gopi Kalathil, Yasmin Thanavala
Focussed Research Review
Tumor-derived factors modulating dendritic cell function
Jinbao Zong, Anton A. Keskinov, Galina V. Shurin, Michael R. Shurin
Focussed Research Review
Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice
Anna K. Kozlowska, Kawaljit Kaur, Paytsar Topchyan, Anahid Jewett
Open Access
Focussed Research Review
How frequently are predicted peptides actually recognized by CD8 cells?
Ioana Moldovan, Oleg Targoni, Wenji Zhang, Srividya Sundararaman, Paul V. Lehmann
Focussed Research Review
Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy
Michal Baniyash
Focussed Research Review
Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells
Leena Chaudhuri, Rupesh K. Srivastava, Ferdynand Kos, Protul A. Shrikant
Meeting Report
Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia
Natalia Aptsiauri, Anahid Jewett, Arthur A. Hurwitz, Michael R. Shurin, Viktor Umansky